Status:
COMPLETED
Functional Plasticity of Human IL-17-producing CD8+ T Cells
Lead Sponsor:
China Medical University Hospital
Conditions:
IL-17+ CD8 T Cells in Cancer Patients
Eligibility:
All Genders
20+ years
Brief Summary
Human Tc17 cells (IL-17-producing CD8+ T cells) have been found to contribute to different kinds of human inflammatory and malignant diseases. Previous studies indicate that Tc17 cells can convert to ...
Eligibility Criteria
Inclusion
- cancer patients
Exclusion
- pregnancy
Key Trial Info
Start Date :
January 25 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 30 2018
Estimated Enrollment :
17 Patients enrolled
Trial Details
Trial ID
NCT03291639
Start Date
January 25 2018
End Date
August 30 2018
Last Update
July 29 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
China Medical University Hospital
Taichung, Taiwan, 404